Price T Rowe Associates Inc Jazz Pharmaceuticals PLC Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 37,143 shares of JAZZ stock, worth $4.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,143

Previous 34,140 8.8%

Holding current value

$4.57 Million

Previous $3.64 Million 13.58%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.57 - $116.37 $302,011 - $349,459	3,003 Added 8.8%	37,143 $4.14 Million
Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $136,888 - $156,696	1,317 Added 4.01%	34,140 $3.64 Million
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $1.79 Million - $2.06 Million	-15,521 Reduced 32.11%	32,823 $3.95 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $2.15 Million - $2.56 Million	18,796 Added 63.61%	48,344 $5.95 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $83,082 - $98,956	-681 Reduced 2.25%	29,548 $3.83 Million
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $30,992 - $37,231	-253 Reduced 0.83%	30,229 $3.75 Million
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $332,404 - $398,126	-2,481 Reduced 7.53%	30,482 $4.46 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $118,174 - $145,623	911 Added 2.84%	32,963 $5.25 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $675,484 - $860,056	5,336 Added 19.97%	32,052 $4.27 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $49,556 - $59,031	350 Added 1.33%	26,716 $4.17 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $332,267 - $411,874	2,563 Added 10.77%	26,366 $4.1 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $567,224 - $689,310	-4,732 Reduced 16.58%	23,803 $3.03 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $28,300 - $40,653	220 Added 0.78%	28,535 $3.72 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $546,602 - $636,065	3,412 Added 13.7%	28,315 $5.03 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $57.1 Million - $66 Million	-380,467 Reduced 93.86%	24,903 $4.09 Million
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $57 Million - $66.9 Million	405,370 New	405,370 $66.9 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Jazz Pharmaceuticals PLC Transaction History